Wednesday, July 30, 2014
YOLO COUNTY NEWS
99 CENTS

Sickle cell drug shows promise in UCD trial

By
From page A8 | July 06, 2014 |

A UC Davis clinical trial has found safe a drug designed to treat a common, painful complication of sickle cell disease.

There are currently no specific treatments for vaso-occlusive crises, during which clumped-together blood cells hinder blood flow. It is responsible for more than 70,000 hospitalizations annually, according to Ted Wun, associate dean for research at the UCD School of Medicine.

The 15-patient trial found no severe side-effects from the drug, dubbed GMI 1070, and that it was maintaining adequate concentrations in the blood.

Published online in the journal Public Library of Science ONE, the study was not aimed at determining the drug’s effectiveness, but Wun said it did show small improvements in blood flow and reduced the markers of cell activation.

Sickle cell disease, which lowers life expectancy by 20 to 30 years, affects an estimated 90,000 to 100,000 Americans, mostly blacks, according to the U.S. Centers for Disease Control and Prevention.

It is caused by abnormal hemoglobin that contorts red blood cells into a sickle shape, making them stiff and sticky. These clumped cells reduce blood flow, leading to severe hip, back and long-bone pain, and, often, chest and abdominal pain.

“White blood cells bind to inflamed blood vessel walls and sickle red cells stick to white cells, but interestingly the initiating event is the white cells,” Wun said in a news release. “If we could interrupt that white cell interaction, we could stop the cycle that leads to vaso-occlusions.”

The new drug is designed to do that by mimicking sugars attached to cell-adhesion proteins, called selectins, reducing the stickiness and increasing blood flow.

Sickle cell most often strikes the kidneys, lungs and spleen, but it can affect any organ. Stroke, infections, hypertension and heart failure are among its severe complications.

Patients in the trial tolerated the drug well, with headaches the most common side-effect. Preliminary results of a second trial also have been positive, and have been submitted for publication, according to researchers. A third phase is planned.

“If the phase III study confirms that GMI 1070 is effective, it would be a huge advance for the sickle cell community,” Wun said.

GlycoMimetics Inc., a Maryland-based biotechnology company based in Gaithersburg, produces the new drug under the trade name Rivipansel. The company paid for the trial.

Also this week, National Institutes of Health scientists announced the results of a study that found bone marrow transplants can reverse sickle cell disease. The transplant worked in 26 of 30 adults, and 15 of them were even able to stop taking drugs that prevent rejection one year later.

The treatment is a modified version of bone marrow transplants that have worked in children. Donors are a brother or sister whose stem cell-rich bone marrow is a good match for the patient.

The treatment involves using chemotherapy and radiation to destroy bone marrow before replacing it with healthy donor marrow cells.

Results from the adult study, involving patients aged 29 on average, were published in the Journal of the American Medical Association.

—The Associated Press contributed to this report.

Comments

comments

Cory Golden

Cory Golden

The Enterprise's higher-education and congressional reporter. http://about.me/cory_golden
.

News

 
 
Center for Families hosts Summer Carnival

By Enterprise staff | From Page: A4

Vintage car show planned this fall

By Enterprise staff | From Page: A4

 
Davis native named a Schweitzer Fellow

By Special to The Enterprise | From Page: A4

Share your love of nature with young wetlands visitors

By Special to The Enterprise | From Page: A4 | Gallery

 
Movies in the Park return this fall

By Enterprise staff | From Page: A4

Biggest book sale to date opens Friday at Davis library

By Enterprise staff | From Page: A4

 
Tee off for Davis’ continued prosperity

By Lily Holmes | From Page: A4

Tasting event benefits Yolo Land Trust

By Lily Holmes | From Page: A4

 
Tips, techniques will give you a green thumb

By Enterprise staff | From Page: A5

How the Bockler wasp got its name

By Kathy Keatley Garvey | From Page: A5 | Gallery

 
DHS Class of ’94 set 20th reunion

By Enterprise staff | From Page: A5

Kiwanis golf tournament supports local agencies

By Enterprise staff | From Page: A5

 
Grief support focuses on journaling

By Special to The Enterprise | From Page: A5

Drop off school supplies at Edward Jones offices

By Enterprise staff | From Page: A5

 
Wine-tastings will benefit YCCC

By Enterprise staff | From Page: A5

Yolo County CASA seeks volunteer child advocates

By Enterprise staff | From Page: A7

 
UC Davis alumnus hopes to bring amateur radio to Nepal

By Rachel Uda | From Page: A7 | Gallery

Recycle old paint cans for free

By Enterprise staff | From Page: A8

 
.

Forum

Violence as entertainment

By Letters to the Editor | From Page: A6

 
Shocked at vampires story

By Letters to the Editor | From Page: A6

Paul Krugman: Corporate artful dodgers

By Paul Krugman | From Page: A6

 
Nicholas Kristof: The world’s coolest places

By Nicholas Kristof | From Page: A6

Tom Meyer cartoon

By Debbie Davis | From Page: A6

 
Gravel mining affects us all

By Letters to the Editor | From Page: A6

.

Sports

Morse homers but Giants lose 6th straight

By The Associated Press | From Page: B1

 
Nightmare on Ballpark Drive for River Cats

By Will Bellamy | From Page: B1 | Gallery

Fiona Buck pushes the limits in para-athletics

By Felicia Alvarez | From Page: B1 | Gallery

 
A’s rally to win

By The Associated Press | From Page: B1

Schaub settles in as Raiders starting QB

By The Associated Press | From Page: B2

 
.

Features

.

Arts

RootStock kicks off ‘Día de Albariño’

By Enterprise staff | From Page: A9

 
Folk musicians will jam in the Arboretum

By Enterprise staff | From Page: A9

YoloArts to host a state of change exhibit

By Enterprise staff | From Page: A9

 
UCD professor Andy Jones named Davis’ new poet laureate

By Rachel Uda | From Page: A9 | Gallery

 
Molten art on display at Davis Arts Center

By Enterprise staff | From Page: A9

Brady earns top honors at State Fair

By Enterprise staff | From Page: A9

 
Smither releases new CD Saturday at The Palms

By Kate Laddish | From Page: A9 | Gallery

.

Business

.

Obituaries

.

Comics

Comics: Wednesday, July 30, 2014

By Creator | From Page: B6